These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 33395782)

  • 1. New onset diabetes, type 1 diabetes and COVID-19.
    Boddu SK; Aurangabadkar G; Kuchay MS
    Diabetes Metab Syndr; 2020; 14(6):2211-2217. PubMed ID: 33395782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies.
    Rahmati M; Yon DK; Lee SW; Udeh R; McEVoy M; Kim MS; Gyasi RM; Oh H; López Sánchez GF; Jacob L; Li Y; Koyanagi A; Shin JI; Smith L
    J Med Virol; 2023 Jun; 95(6):e28833. PubMed ID: 37264687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of the SARS-CoV-2 Pandemic on Presentation with Diabetic Ketoacidosis in Children with New Onset Type 1 Diabetes Mellitus.
    Jalilova A; Ata A; Demir G; Işıklar H; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):264-267. PubMed ID: 36987789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Positive Serology and Islet Autoantibodies in Newly Diagnosed Pediatric Cases of Type 1 Diabetes Mellitus: A Single-Center Cohort Study.
    Boboc AA; Novac CN; Marin AG; Ieșanu MI; Plătică C; Buzescu T; Coșoreanu MT; Galoș F
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19.
    Kuchay MS; Reddy PK; Gagneja S; Mathew A; Mishra SK
    Diabetes Metab Syndr; 2020; 14(6):2039-2041. PubMed ID: 33113470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor.
    Oz M; Lorke DE; Kabbani N
    Pharmacol Ther; 2021 May; 221():107750. PubMed ID: 33275999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
    Subbaram K; Ali PSS; Ali S
    Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
    Danser AHJ; Epstein M; Batlle D
    Hypertension; 2020 Jun; 75(6):1382-1385. PubMed ID: 32208987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB.
    Rico-Mesa JS; White A; Anderson AS
    Curr Cardiol Rep; 2020 Apr; 22(5):31. PubMed ID: 32291526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
    Jagat J M; Kalyan K G; Subir R
    Diabetes Metab Syndr; 2020; 14(5):829-831. PubMed ID: 32540737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 diabetes mellitus and SARS-CoV-2 in pediatric and adult patients - Data from the DPV network.
    Büttner BR; Tittel SR; Kamrath C; Karges B; Köstner K; Melmer A; Müller-Roßberg E; Richter F; Rohrer TR; Holl RW
    J Diabetes; 2022 Nov; 14(11):758-766. PubMed ID: 36443963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection in hospitalized children with type 1 and type 2 diabetes.
    Trieu C; Sunil B; Ashraf AP; Cooper J; Yarbrough A; Pinninti S; Boppana S
    J Clin Transl Endocrinol; 2021 Dec; 26():100271. PubMed ID: 34729361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 Diabetes and COVID-19: A Literature Review and Possible Management.
    Kashfi K; Anbardar N; Asadipooya A; Asadipooya K
    Int J Endocrinol Metab; 2023 Oct; 21(4):e139768. PubMed ID: 38666042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the gene expression of SARS-COV-2 entry receptors and enzymes in lungs and hearts of controlled and uncontrolled diabetic mice.
    Alkhawaldeh O; Jarrar Y; Gharaibeh M; Abudahab S; Abulebdah D; Jarrar B
    Fundam Clin Pharmacol; 2024 Apr; 38(2):328-340. PubMed ID: 37950353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.
    Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing of RAS-Pathway Mediated Drugs for Intestinal Inflammation Related Diseases for Treating SARS-CoV-2 Infection.
    Sinha A; Vaggu RG; Swain R; Patnaik S
    Curr Microbiol; 2023 Apr; 80(6):194. PubMed ID: 37106165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus disease 2019 and type 1 diabetes mellitus.
    Chang DJ; Moin T
    Curr Opin Endocrinol Diabetes Obes; 2021 Feb; 28(1):35-42. PubMed ID: 33278126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes.
    Kountouri A; Korakas E; Ikonomidis I; Raptis A; Tentolouris N; Dimitriadis G; Lambadiari V
    Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34065123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.